Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The enzyme-linked immunosorbent assay is a test performed for the detection of presence of antibodies in the liquid biological samples. ELISA is used as quality control check in many industries and as a diagnostic tool in plant pathology and in medicines. The ELISA is commonly used analytical biochemistry assay, which is firstly elaborated by Engvall and Perimann in 1971. The assay uses a solid phase type of enzyme immunoassay for detection of presence of ligand which is generally a protein in the liquid biological samples by the use of antibodies directed against the protein which has to be measured.
The Europe enzyme-linked immunosorbent assay market is witnessing rapid growth during the forecast period of 2019 - 2028. The ELISA has been used as a diagnostic tool in medicine, plant pathology and biotechnology as well as a quality control check in the different industries. The dynamic factors such as emergence of cost-effective technology is propelling growth of Europe enzyme-linked immunosorbent assay market. The increasing laboratory automation is also boosting growth of Europe enzyme-linked immunosorbent assay market. However, stringent requirement for the approval of immunoassay instrument is hampering the growth of Europe enzyme-linked immunosorbent assay market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the Enzyme-linked immunosorbent assay market. In addition, complete analysis of changes on Enzyme-linked immunosorbent assay expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Europe economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 has almost affected every market is healthcare industries positively or negatively. The rising cases of COVID-19 and adoption of technically advanced test for detection of infectious diseases in patients is rising demand of Enzyme-linked immunosorbent assay. The Enzyme-linked immunosorbent assay test is more sensitive than other tests for detection of infectious disease in patients. Thereby, the Enzyme-linked immunosorbent assay market has positive impact of COVID-19.
The Europe Enzyme-Linked Immunosorbent Assay Market is categorised into the type, application, end user and country.
Based on type, the Europe enzyme-linked immunosorbent assay market is segmented into the sandwich ELISA, indirect ELISA, direct ELISA and competitive ELISA. In which sandwich ELISA is also contributing to the growth of Europe enzyme-linked immunosorbent assay market. The sandwich ELISA uses two antibodies in which one is capture antibody and detection antibody. The purpose of the sandwich ELISA test is to detect the presence of the target antigen in the sample. In the sandwich ELISA the target antigen is bound between a capture antibody and a detection antibody. The captured antibody is immobilised on a surface. Whereas the detection antibody which is conjugated to an enzyme or fluorophore label is applied as a last step before quantification.
Based on application, the Europe enzyme-linked immunosorbent assay market is categorised into the vaccine development, immunology, diagnostic, toxicology, drug monitoring and pharmaceutical and transplantation. In which immunology is also contributing to the growth of the market in 2020. The ELISA is commonly used in the detection of HIV, pregnancy and the measurement of cytokines and soluble receptors. The rising challenges in healthcare industry due to immunological disorders is boosting growth of Europe enzyme-linked immunosorbent assay market.
Based on end user, the Europe enzyme linked immunosorbent assay market is bifurcated into hospital and diagnostic centres, research laboratories and other. In which the hospital and diagnostic centres is expected to dominate the market in 2020. The rising prevalence of chronic diseases is propelling growth of Europe enzyme-linked immunosorbent assay market. The growing demand for early diagnosis is also boosting growth of Europe enzyme-linked immunosorbent assay market.
The Europe enzyme-linked immunosorbent assay market is studied for key countries such as UK, Germany, France, Italy and Spain. In which United Kingdom is anticipated to dominate the market in 2020. The growing healthcare expenditures is boosting growth of Europe enzyme-linked immunosorbent assay market. The increasing prevalence of chronic and infectious diseases is also propelling growth of Europe enzyme-linked immunosorbent assay market.
The major key players of Enzyme-linked immunosorbent assay market are Alpco, Abcam Plc, Agilent Technologies Inc., BD Biosciences, Bio-Rad Laboratories Inc., Biolegend Inc., Enzo Life Sciences Inc., F. Hoffmann-La Roche Ltd., Merck Kgaa, Mercodia Ab, Ortho-Clinical Diagnostics Inc., Perkinelmer Inc., Qiagen Nv, R&D Systems Inc., Shenzen Yhlo Biotech Co. Ltd., Thermo Fischer Scientific Inc., Zeus Scientific, Inc. and Biomérieux Sa among others.
February 2021: The Thermo Fisher Scientific Inc., acquired the private point of care molecular diagnostic company named as Mesa Biotech.
February 2020: The Becton Dickinson and Co. reported a collaborated with Babson Diagnostic for bringing lab quality, little volume blood assortment to retail drug stores.
March 2018: BARD1 Life sciences, The U.S. based science research company is expected the commercialization of BARD1-Ovarian blood based ELSIA test for distinguishing ovarian diseases in the beginning phase.
January 2018: The Eagle Biosciences Inc., presented a novel unblemished FGF23 ELISA unit test which is the 96 well sandwich ELISA examination. It is estimated as full-length dynamic type of human Intact FGF23 utilized for the discovery of mineral bone disorder, chronic kidney disorder, chronic kidney disease and hyperphosphatemia.
The report analyses the Enzyme-linked immunosorbent assay market based on type, application, end user and country. The various type of ELISA test covered in the report are sandwich ELISA, indirect ELISA, direct ELISA and competitive ELISA. By application, the market is segmented into the vaccine development, immunology, diagnostics, toxicology, drug monitoring and pharmaceuticals and transplantation. Based on end user, the market is segmented into the hospital and diagnostic centre, research laboratories and other. The report also analyses the impact of COVID-19 on the Enzyme-linked immunosorbent assay market and it is analyses that the COVID-19 has almost affected every market is healthcare industries positively or negatively. The rising cases of COVID-19 and adoption of technically advanced test for detection of infectious diseases in patients is rising demand of Enzyme-linked immunosorbent assay. The Enzyme-linked immunosorbent assay test is more sensitive than other tests for detection of infectious disease in patients. Thereby, the Enzyme-linked immunosorbent assay market has positive impact of COVID-19. The report also covers the major key players operating in the market.
Why to buy this report
